Sovrinti Chosen as Finalist in Prestigious NIH National A2 Investment Conference

Sovrinti Inc. has achieved a significant milestone by being named one of nine finalists for a prestigious pitch competition at the National A2 Investment Conference. The event, scheduled for March 8, 2023, in Baltimore, is dedicated to supporting the commercialization of innovative startup companies selected under the NIH/NIH A2 program, focusing on AI-based senior care solutions.

Selected from a pool of A2 participant startups, Sovrinti earned its place among the finalists through its pioneering efforts in developing AI techniques to identify rising risks among seniors for acute events. The finalists were chosen by a panel of esteemed commercialization experts from Johns Hopkins University, UPenn, and UMass, representing the three centers for A2 development.

Sovrinti's participation in the competition is supported by the JHU AI Technology Collaboration for Aging Research under NIH/NIA Award Number P30AG073104, highlighting its commitment to advancing technology-driven solutions for elder care.